yep DDD, its tough at the bottom and unfortunately that is our lot currently. We have found multiple veins that are probably all commercial, but none that are ready to commercialise.
Your point has some validity and as a tiny entity, all our prospective funds could get gobbled up by overhead if they wait too long. Looking back, you would say that trenching period was a complete waste of money, in that it did nothing to facilitate development to the next stage of the cycle. All it did was pay dir fees and wages.
But Duffy knows what needs to get done now and presumably has a budget to complete a MRE and move along quickly with a MRE for Limon at least. It will take thousands of metres of drilling to finally size all our reserves.
Hopefully this is the darkest night, but if the raising goes well, we will still wake up with a big hangover; SP down another 40% to 0.5c and facing tipping in another wad to avoid dilution.
I did dump a few after the last drill results, but still this looks like the biggest investment disaster of my life.
good luck
wazz
- Forums
- ASX - By Stock
- STM
- Ann: Trading Halt
Ann: Trading Halt, page-30
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add STM (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.001(14.3%) |
Mkt cap ! $41.19M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.7¢ | $127.6K | 16.04M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
35 | 20867068 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 580000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
35 | 20867068 | 0.007 |
24 | 31954932 | 0.006 |
17 | 7937111 | 0.005 |
19 | 12147891 | 0.004 |
10 | 9585341 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 580000 | 2 |
0.009 | 9773398 | 13 |
0.010 | 10679576 | 13 |
0.011 | 5190999 | 5 |
0.012 | 7100133 | 9 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
STM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online